Similar Search Results

Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010

a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub …We study the impact of regulation on competition between brand-names and generics and pharmaceutical expenditures using …-sample of off-patent products. First, we construct a vertical differentiation model to analyze the impact of regulation on …

Persistent link: https://www.econbiz.de/10010274913

Supplementary private health insurance in selected countries : lessons for EU governments?

Gechert, Sebastian - 2009

A famous idea to maintain affordable health expenditures is to cut back statutory health insurance (SHI) to a basic insurance and to introduce supplementary private health insurance (PHI), permitted to cover the remaining benefits and to apply managed care mechanisms. The measure is supposed to...

Persistent link: https://www.econbiz.de/10010266017

Taxing sin goods and subsidizing health care

Cremer, Helmuth; de Donder, Philippe; Maldonado, Darío; … - 2008

We consider a two-period model. In the first period, individuals consume two goods: one is sinful and the other is not. The sin good brings pleasure but has a detrimental effect on second period health and individuals tend to underestimate this effect. In the second period, individuals can...

Persistent link: https://www.econbiz.de/10010273775

Choosing among competing blockbusters: Does the identity of the third-party payer matter for prescribing doctors?

Dalen, Dag Morten; Sorisio, Enrico; Strøm, Steinar - 2010

accounting for 8 % of total pharmaceutical sale in Norway. With use of a unique natural policy experiment in Norway, this paper …

Persistent link: https://www.econbiz.de/10010274801

Margins and market shares: Pharmacy incentives for generic substitution

Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012

coinsurance. In terms of policy implications, our results suggest that pharmacy incentives are crucial for promoting generic sales. …

Persistent link: https://www.econbiz.de/10010291561

Physician Density and Infant Mortality : A Semiparametric Analysis of the Returns to Health Care Provision

Liebert, Helge - 2018

This paper investigates the effect of physicians on infant mortality, stillbirths and the incidence of common childhood diseases. We construct a new panel data set covering German municipalities from 1928 to 1936 based on historical sources. The endogeneity of health care supply is addressed by...

Persistent link: https://www.econbiz.de/10012908713

Coinsurance vs. Copayments : Reimbursement Rules for a Monopolistic Medical Product with Competitive Health Insurers

Cremer, Helmuth; Lozachmeur, Jean-Marie - 2021

higher level of welfare for consumers. This results provides strong support for a reference price based reimbursement policy …

Persistent link: https://www.econbiz.de/10013221173

Physicians and the Production of Health : Returns to Health Care During the Mortality Transition

Liebert, Helge; Mäder, Beatrice - 2022

This paper investigates the returns to health care provision during the mortality transition. We construct a new panel data set covering German municipalities from 1928 to 1936. The endogeneity of health care supply is addressed by using the expulsion of Jewish physicians from statutory health...

Persistent link: https://www.econbiz.de/10013292046

‘Investing’ in Care for Old Age? An Examination of Long-Term Care Expenditure Dynamics and Its Spillovers

Costa-Font, Joan; Vilaplana-Prieto, Cristina - 2022

We first study the dynamic drivers of expenditure on long-term care (LTC) programs, and more specifically, the effects of labour market participation of traditional unpaid caregivers (women aged 40 and older) on LTC spending. Second, we examine spillover effects of a rise on LTC expenditure on...

Persistent link: https://www.econbiz.de/10013306397